atezolizumab
roche
['atezo', 'cll']
atezolizumab (anti-pdl1) + vo for richters. 43% had a tp53 aberration and 90% with clinal relation to prior cll. well-tolerated with very reasonable response rates. #17icml 
#Lymphoma Doc. Faculty at @UCIrvineHealth. Buffalo born, @HarvardMed trained. Tweets are mine & not medical advice.